Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 5 (2008), Issue 2 (February)

1. Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
   Cancer Res, 68(3): 834-42. [Abstract] [Full-text]
2. CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
   Cancer Res, 68(3): 715-23. [Abstract] [Full-text]
3. Modeling genomic diversity and tumor dependency in malignant melanoma.
   Cancer Res, 68(3): 664-73. [Abstract] [Full-text]
4. In vivo switching of human melanoma cells between proliferative and invasive states.
   Cancer Res, 68(3): 650-6. [Abstract] [Full-text]
5. Quinones are reduced by 6-tetrahydrobiopterin in human keratinocytes, melanocytes, and melanoma cells.
   Free Radic Biol Med, 44(4): 538-46. [Abstract] [Full-text]
6. SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
   Int J Cancer, 122(7): 1465-75. [Abstract] [Full-text]
7. The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
   Int J Cancer, 122(7): 1548-56. [Abstract] [Full-text]
8. Metastatic rhabdoid melanoma: report of a case with a comparative review of the literature.
   J Cutan Pathol, 35(3): 337-42. [Abstract] [Full-text]
9. Immunohistochemical detection of XIAP in melanoma.
   J Cutan Pathol, 35(3): 292-7. [Abstract] [Full-text]
10. High numbers of human skin cancers express MMP2 and several integrin genes.
    J Cutan Pathol, 35(3): 285-91. [Abstract] [Full-text]
11. Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry.
    Ann Surg Oncol, 15(3): 934-40. [Abstract] [Full-text]
12. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study.
    Arch Ophthalmol, 126(2): 207-12. [Abstract] [Full-text]
13. Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma.
    J Invest Dermatol, 128(3): 676-84. [Abstract] [Full-text]
14. Suicide gene and cytokines combined nonviral gene therapy for spontaneous canine melanoma.
    Cancer Gene Ther, 15(3): 165-72. [Abstract] [Full-text]
15. Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.
    J Clin Oncol, 26(6): 955-62. [Abstract] [Full-text]
16. BRAF kinase in melanoma development and progression.
    Expert Rev Mol Med, 10: e6. [Abstract] [Full-text]
17. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
    Int Immunopharmacol, 8(3): 442-52. [Abstract] [Full-text]
18. Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35.
    Clin Immunol, 126(3): 251-9. [Abstract] [Full-text]
19. Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas.
    Am J Ophthalmol, 145(3): 418-423. [Abstract] [Full-text]
20. Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice.
    Eur J Pain, 12(3): 293-300. [Abstract] [Full-text]
21. Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells.
    J Pharmacol Exp Ther, 324(3): 1093-101. [Abstract] [Full-text]
22. A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
    Cancer Immunol Immunother, 57(5): 745-52. [Abstract] [Full-text]
23. Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells.
    Cancer Immunol Immunother, 57(5): 647-54. [Abstract] [Full-text]
24. Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
    Cancer Immunol Immunother, 57(5): 719-29. [Abstract] [Full-text]
25. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.
    Cancer Immunol Immunother, 57(5): 685-91. [Abstract] [Full-text]
26. Pathobiology of the sentinel node.
    Curr Opin Oncol, 20(2): 190-5. [Abstract] [Full-text]
27. The MAPK pathway in melanoma.
    Curr Opin Oncol, 20(2): 183-9. [Abstract] [Full-text]
28. Cancer testis antigens in human melanoma stem cells: expression, distribution, and methylation status.
    J Cell Physiol, 215(2): 287-91. [Abstract] [Full-text]
29. Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth.
    J Cell Physiol, 215(2): 434-41. [Abstract] [Full-text]
30. HSP90 as a marker of progression in melanoma.
    Ann Oncol, 19(3): 590-4. [Abstract] [Full-text]
31. Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site.
    Ann Oncol, 19(3): 583-9. [Abstract] [Full-text]
32. The correlation of regression in primary melanoma with sentinel lymph node status.
    J Clin Pathol, 61(3): 297-300. [Abstract] [Full-text]
33. Melanoma adrenal metastasis: natural history and surgical management.
    Am J Surg, 195(3): 363-8; discussion 368-9. [Abstract] [Full-text]
34. Cytotoxic effect of sodium hypochlorite 0.5% (NaOCl) on ocular melanoma cells in vitro.
    Orbit, 27(1): 31-5. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.